Rospotrebnadzor told about the vaccine "Vector" against coronavirus

This was reported by RIA Novosti with reference to the press service of Rospotrebnadzor.

It is noted that the development of the EpiVacCorona vaccine by the Vector Center takes into account all the mandatory requirements and regulatory recommendations provided for by Russian legislation.

Also "Vector" follows the recommendations of the World Health Organization, vaccine research protocols take into account domestic and international experience.

“Strict adherence to the rules for conducting preclinical and clinical trials gives confidence in obtaining a safe and high-quality vaccine for the residents of the Russian Federation,” the center said.

Earlier, Rospotrebnadzor told about the progress of testing the vaccine "Vector" against COVID-19.